{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:39:13Z","timestamp":1791895153686,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1111\/1469-0691.12380","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T04:08:49Z","timestamp":1377749329000},"page":"O245-O254","source":"Crossref","is-referenced-by-count":266,"title":["Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain"],"prefix":"10.1016","volume":"20","author":[{"given":"M.","family":"Puig-Asensio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Garnacho-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Zaragoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zaragoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Montejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ruiz-Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Almirante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12380_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991\u20132000","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12380_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2334-10-312","article-title":"Secular trend in candidemia and the use of fluconazole in Finland, 2004\u20132007","volume":"10","author":"Poikonen","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1111\/1469-0691.12380_bib3","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/JCM.00029-06","article-title":"Candidemia in Norway (1991 to 2003): results from a nationwide study","volume":"44","author":"Sandven","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12380_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.01811-10","article-title":"National surveillance of fungemia in Denmark (2004 to 2009)","volume":"49","author":"Arendrup","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12380_bib5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/JCM.02566-12","article-title":"Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011","volume":"51","author":"Asmundsdottir","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12380_bib6","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003","volume":"43","author":"Almirante","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12380_bib7","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12380_bib8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12380_bib9","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1086\/313450","article-title":"The epidemiology of candidemia in two United States cities: results of a population-based active surveillance","volume":"29","author":"Kao","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12380_bib10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JCM.40.4.1298-1302.2002","article-title":"Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study","volume":"40","author":"Diekema","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12380_bib11","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program","volume":"42","author":"Hajjeh","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12380_bib12","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12380_bib13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.eimc.2010.12.003","article-title":"Candidemias: multicentre analysis in 16 hospitals in Andalusia (Spain)","volume":"29","author":"Rodriguez-Hernandez","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/1469-0691.12380_bib14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/jac\/dks019","article-title":"Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey","volume":"67","author":"Peman","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12380_bib15","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12380_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","article-title":"Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12380_bib17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/jac\/dkr511","article-title":"Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes","volume":"67","author":"Grim","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12380_bib18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12380_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jac\/dks347","article-title":"Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections","volume":"68","author":"Garnacho-Montero","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12380_bib20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1469-0691.2007.01758.x","article-title":"Impact of early central venous catheter removal on outcome in patients with candidaemia","volume":"13","author":"Rodriguez","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12380_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1111\/1469-0691.12380_bib22","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"10.1111\/1469-0691.12380_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12380_bib24","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1128\/JCM.40.8.2860-2865.2002","article-title":"Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR","volume":"40","author":"Luo","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12380_bib25","series-title":"PCR protocols: a guide to methods and applications","first-page":"315","article-title":"Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics","author":"White","year":"1990"},{"key":"10.1111\/1469-0691.12380_bib26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","article-title":"EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts","volume":"14","author":"Rodriguez-Tudela","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12380_bib27","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12380_bib28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/01.inf.0000202127.43695.06","article-title":"Candidemia in neonatal intensive care units: Barcelona, Spain","volume":"25","author":"Rodriguez","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/1469-0691.12380_bib29","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JCM.05474-11","article-title":"Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey","volume":"49","author":"Peman","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12380_bib30","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1128\/JCM.44.5.1681-1685.2006","article-title":"Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case\u2013control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003","volume":"44","author":"Almirante","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"Suppl 7","key":"10.1111\/1469-0691.12380_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: Prevention and management of invasive infections in neonates and children caused by Candida spp","volume":"18","author":"Hope","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12380_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12380_bib33","first-page":"30","article-title":"Epidemiology of candidemia in Spain\u2014multicenter study","volume":"19","author":"Peman","year":"2002","journal-title":"Rev Iberoam Micol"},{"key":"10.1111\/1469-0691.12380_bib34","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/AAC.49.11.4555-4560.2005","article-title":"Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case\u2013case\u2013control study","volume":"49","author":"Lin","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12380_bib35","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1086\/432939","article-title":"Candida glabrata fungemia: experience in a tertiary care center","volume":"41","author":"Malani","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12380_bib36","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/jac\/dkh548","article-title":"In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002\u20132003","volume":"55","author":"Cuenca-Estrella","year":"2005","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14602974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14602974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T12:28:07Z","timestamp":1539433687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14602974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1198743X14602974"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12380","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}